Access Statistics for Bruno Versaevel

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 0 15
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 1 28
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 1 13
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 0 12
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 1 2 11
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 0 9
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 1 2 5
Better than a compromise, a third way: patent pool to accelerate access to vaccines and treatments against Covid-19 0 0 1 1 2 2 3 7
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 1 1 2 12 1 1 3 20
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 0 1 3 3 5
Caveat Preemptor: Coordination Failure and Success in a Duopoly Investment Game 0 0 0 0 1 1 3 37
Conflict and Cooperation on R&D Markets 0 0 0 90 0 0 2 284
Coordination and Cooperation in Investment Timing with Externalities? 0 0 0 17 1 1 1 102
Covid-19: Should intellectual property rights be challenged? 0 0 0 8 1 1 2 74
Dynamic competition and intellectual property rights in a model of product development 0 0 0 0 0 0 0 35
Dynamic competition and intellectual property rights in a model of product development 0 0 0 0 0 0 0 18
Dynamique des marchés et ajustement de la protection Intellectuelle 0 0 0 0 0 0 1 14
Dynamique des marchés et ajustement de la protection intellectuelle 0 0 0 0 1 1 1 9
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 2 3 3 9
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 0 28
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 1 1 1 18
From Private to Public Common Agency 0 0 0 0 0 0 0 40
From private to public common agency 0 0 0 0 0 0 0 7
Horizontal R&D Cooperation and Spillovers: Evidence from France 0 0 0 0 1 1 1 8
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 1 1 1 9
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 0 1 1 16
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 0 1 31
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 0 0 31
Innovation and imitation incentives in dynamic duopoly 0 0 0 49 0 0 1 93
Investment Timing and Vertical Relationships 0 0 0 37 0 0 0 89
Investment timing and vertical relationships 0 0 0 0 0 0 0 8
Market Share, R&D Cooperation, and EU Competition Policy 1 1 1 2 2 2 2 27
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 2 2 3 15
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 0 1 31
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 0 3
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 1 14
On the Optimal Timing of Innovation and Imitation 0 0 0 0 0 0 0 16
On the Timing of Vertical Relationships 0 0 0 45 0 0 0 80
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 0 0 0 1 10
On the timing of innovation and imitation 0 0 0 28 0 0 0 42
On the timing of innovation and imitation in dynamic duopoly 0 0 0 0 0 0 0 10
On the timing of vertical relationships 0 0 0 36 0 1 3 70
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 1 2 29
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 1 28 0 0 3 58
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 0 1 13
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 1 2 11
Optimal Collusion with Limited Liability 0 0 0 0 2 2 3 35
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 52 1 1 1 119
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 0 0 0 0 22
Optimal collusion with limited liability 0 0 0 40 0 0 0 87
Patent Pools and Dynamic R&D Incentives 0 0 0 0 0 0 0 22
Patent Pools and R&D Dynamics 0 0 0 0 0 0 0 24
Patent pools and dynamic R&D incentives 0 0 0 0 0 1 1 42
Pool patents to get COVID vaccines and drugs to all 0 0 0 7 0 0 0 33
Quel rôle pour la part de marché quand le droit de la concurrence porte son regard sur la coopération et l'innovation 0 0 0 0 0 0 0 11
Quel rôle pour un critère de part de marché dans la réglementation de la coopération en recherche et développement ? 0 0 0 0 2 2 2 8
Quelles spécificités des accords de distribution en ligne ? 0 0 0 0 0 0 0 7
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 1 12
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 0 1
Tacit Collusion in Investment Timing 0 0 0 0 0 0 0 16
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 32 0 0 0 131
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 0 3 249
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 0 1 243
Timing Vertical Relationships 0 0 0 0 0 0 0 20
Timing Vertical Relationships 0 0 0 0 0 0 0 21
Timing Vertical Relationships 0 0 0 0 1 1 2 16
Timing Vertical Relationships 0 0 0 0 0 0 0 25
Timing Vertical Relationships 0 0 0 0 1 2 2 24
Timing Vertical Relationships 0 0 0 53 0 0 0 72
When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly 0 0 0 77 0 0 0 53
Total Working Papers 2 2 5 709 24 35 69 2,807
3 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 1 2 1 1 2 37
Caveat preemptor: Coordination failure and success in a duopoly investment game 0 0 0 11 3 4 4 107
Co-ordination costs and vertical integration in production franchise networks: a common agency model 0 0 0 46 0 0 1 136
Dynamic competition and intellectual property rights in a model of product development 0 0 0 7 1 3 5 77
From private to public common agency 0 0 0 28 0 0 0 117
Horizontal R and D cooperation and spillovers: evidence from France 0 0 0 5 1 1 2 42
Investment timing and vertical relationships 0 0 0 16 1 1 2 46
La spéculation sur le marché des actions: un phénomène monétaire ? 0 0 0 1 0 0 0 18
Market shares, R&D agreements, and the EU block exemption 0 0 0 11 0 0 1 81
Mieux qu’un compromis, une troisième voie: le panier de brevets pour accélérer l’accès aux vaccins et traitements contre la COVID-19 0 0 0 5 0 0 0 10
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 12 1 1 1 77
One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 2 0 2 5 41
Optimal collusion with limited liability 0 0 0 9 0 0 0 64
Patent pools and dynamic R&D incentives 0 0 0 27 1 2 6 114
Pool patents to get COVID vaccines and drugs to all 0 0 0 3 0 1 3 10
R&D Delegation in a Duopoly with Spillovers 0 0 0 25 0 0 1 107
Total Journal Articles 0 0 1 210 9 16 33 1,084


Statistics updated 2025-03-03